Bausch + Lomb eyes AU$1.2 billion in IPO
Ophthalmic giant Bausch + Lomb (B+L), which is being spun-off from its parent as a pure-play eye health company, has ...
Tag: B+L
Eyecare spin-off Bausch + Lomb files for IPO
Almost 18 months since its parent company announced Bausch + Lomb (B+L) would be spun off as a pure-play eye ...
Rethinking what’s possible with the enVista IOL
Bausch + Lomb’s latest version of the enVista monofocal recently became available to Australian and New Zealand surgeons along with ...
TGA approves ‘breakthrough’ B+L contact lens
Bausch + Lomb has obtained regulatory approval to supply its new Ultra One Day daily disposable silicone hydrogel (SiHy daily) ...